Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/4105 stock hub

TPEX/4105 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4105is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.7B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4105

In the news

Latest news · TPEX/4105

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E12.3

P25 14.4P50 18P75 31.9

ROE23.9

P25 -16.2P50 0.3P75 9.8

ROIC24.5

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4105 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

TWD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	342
Enterprise value	TWD 17.3B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0004105002
Last refreshed	2026-05-10
Market cap	TWD 18.7B
Price	TWD 75.4
Price currency	TWD
Rev Per Employee	19,048,494.15x
Sector	Healthcare
Sic	2834
Symbol	tpex/4105
Website	https://www.tty.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.59%
EV Earnings	10.72x
EV/EBIT	8.81x
EV/EBITDA	8.02x
EV/FCF	9.06x
EV/Sales	2.65x
FCF yield	10.17%
P/B ratio	2.53x
P/E ratio	12.26x
P/S ratio	2.88x
PE Ratio10 Y	17.89x
PE Ratio3 Y	14.35x
PE Ratio5 Y	16.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.34%
EBITDA Margin	30.34%
FCF margin	29.26%
Gross margin	57.54%
Gross Profit	TWD 3.7B
Gross Profit Growth	6.29%
Gross Profit Growth Q	3.14%
Gross Profit Growth3 Y	6.74%
Gross Profit Growth5 Y	8.38%
Net Income	TWD 1.6B
Net Income Growth	3.28%
Net Income Growth Q	13.29%
Net Income Growth Years	4%
Net Income Growth3 Y	13.37%
Net Income Growth5 Y	13.02%
Pretax Margin	33.51%
Profit Margin	24.73%
Profit Per Employee	TWD 4.7M
Profitable Years	7
ROA	9.83
Roa5y	8.51
ROCE	22.12
ROE	23.94
Roe5y	18.56
ROIC	24.53
Roic5y	18.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.77%
Cagr15y	2.74%
Cagr1y	5.13%
Cagr20y	14.54%
Cagr3y	4.58%
Cagr5y	5.45%
Div CAGR10	2.54%
Div CAGR3	8.74%
Div CAGR5	2.38%
EPS Growth	-1.78
EPS Growth Q	-36.31
EPS Growth Years	4
EPS Growth3 Y	11.41
EPS Growth5 Y	11.86
FCF Growth	48.35%
FCF Growth Q	61.64%
FCF Growth3 Y	21.69%
FCF Growth5 Y	33.04%
OCF Growth	44.61%
OCF Growth Q	64.83%
OCF Growth10 Y	7.87%
OCF Growth3 Y	20.92%
OCF Growth5 Y	26.69%
Revenue Growth	7.16x
Revenue Growth Q	4.23x
Revenue Growth Years	5x
Revenue Growth3 Y	7.87x
Revenue Growth5 Y	9.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.58
Assets	TWD 11.7B
Cash	TWD 2.8B
Current Assets	TWD 6.2B
Current Liabilities	TWD 3.6B
Debt	TWD 515.1M
Debt EBITDA	TWD 0.26
Debt Equity	TWD 0.07
Debt FCF	TWD 0.27
Equity	TWD 7.4B
Interest Coverage	50.29
Liabilities	TWD 4.3B
Long Term Assets	TWD 5.5B
Long Term Liabilities	TWD 655.8M
Net Cash	TWD 2.3B
Net Cash By Market Cap	TWD 12.3
Net Cash Growth	33.81%
Net Debt EBITDA	TWD -1.17
Net Debt Equity	TWD -0.31
Net Debt FCF	TWD -1.21
Tangible Book Value	TWD 6B
Tangible Book Value Per Share	TWD 13.49
WACC	5.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.71
Inventory Turnover	2.12
Net Working Capital	TWD 254M
Quick ratio	1.16
Working Capital	TWD 2.6B
Working Capital Turnover	TWD 2.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.24%
Dividend Growth	7.14%
Dividend Growth Years	3%
Dividend per share	TWD 4.5
Dividend Years	24
Dividend Yield	5.97%
Ex Div Date	2026-03-26
Last Dividend	TWD 4.5
Payout Frequency	Annual
Payout Ratio	64.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	19.22%
1Y total return	5.12%
200-day SMA	79.13
3Y total return	14.39%
50-day SMA	77.25
50-day SMA vs 200-day SMA	50under200
5Y total return	30.41%
All Time High	137
All Time High Change	-44.96%
All Time High Date	2016-10-03
All Time Low	6.05
All Time Low Change	1,146.08%
All Time Low Date	2001-10-05
ATR	1.1
Beta	0.17
Beta1y	0.2
Beta2y	0.22
Ch YTD	-7.48
High	75.6
High52	87
High52 Date	2026-01-28
High52ch	-13.33%
Low	74.2
Low52	71.6
Low52 Date	2026-04-27
Low52ch	5.31%
Ma50ch	-2.39%
Price vs 200-day SMA	-4.72%
RSI	54.16
RSI Monthly	46.92
RSI Weekly	41.84
Sharpe ratio	0.36x
Sortino ratio	0.98
Total Return	0.73%
Tr YTD	-1.97
Tr15y	49.9%
Tr1m	1.62%
Tr1w	2.17%
Tr3m	-5.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 1.8B
Operating Income Growth	19.06
Operating Income Growth Q	18.76
Operating Income Growth3 Y	13.24
Operating Income Growth5 Y	14.81
Operating margin	27.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	198,561,309%
Net Borrowing	-508,930,000
Shares Insiders	10.52%
Shares Institutions	9.33%
Shares Out	248,650,000
Shares Qo Q	77.28%
Shares Yo Y	5.24%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 1.9B
Average Volume	878,894.2x
Bv Per Share	14.82
CAPEX	TWD -113M
Ch10y	-28.87
Ch15y	-17.25
Ch1m	1.62
Ch1w	2.17
Ch1y	-0.79
Ch20y	592
Ch3m	-10.77
Ch3y	-2.2
Ch5y	-2.84
Ch6m	-4.92
Change	1.21%
Change From Open	1.62
Close	74.5
Days Gap	-0.4
Depreciation Amortization	195,237,000
Dollar Volume	68,742,406.2
Earnings Date	2026-03-27
EBIT	TWD 1.8B
EBITDA	TWD 2B
EPS	TWD 6.15
F Score	5
FCF	TWD 1.9B
FCF EV Yield	11.04x
FCF Per Share	TWD 7.67
Financing CF	-1,593,517,000
Fiscal Year End	December
Founded	1,960
Graham Number	45.28491
Graham Upside	-39.94
Income Tax	TWD 473.4M
Investing CF	-431,277,000
Is Primary Listing	1
Last Earnings Date	2025-11-04
Last Report Date	2026-03-31
Last Split Date	2014-08-13
Last Split Type	Forward
Lynch Fair Value	TWD 80.03
Lynch Upside	6.15
Ma150	80.06
Ma150ch	-5.82%
Ma20	73.8
Ma20ch	2.17%
Net CF	-49,968,000
Open	74.2
P FCF Ratio	9.84
P OCF Ratio	9.29
Payment Date	2026-04-27
Position In Range	85.71
Ppne	2,176,042,000
Price Date	2026-05-08
Price EBITDA	TWD 9.49
Ptbv Ratio	3.14
Relative Volume	1.05x
Revenue	6,514,585,000x
Tax By Revenue	7.27x
Tax Rate	21.68%
Tr20y	1,409.29%
Tr6m	0.75%
Volume	911,703

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4105 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+6.0%

$4.50 annual per share

Payout ratio

+64.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+2.4%

3 consecutive years of growth

Total shareholder yield

+0.7%

Next ex-dividend date: 2026-03-26

Performance

TPEX/4105 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4105?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.3%

Share of float held by funds and institutions

Insider ownership

+10.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.2%

Negative means the company is buying back shares.

Technical

TPEX/4105 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.2

Neutral momentum band

Price vs 200-day MA

-4.7%

50/200-day relationship not available

Beta (5Y)

0.17

Less volatile than the market

Sharpe ratio

0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4105

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4105 stock rating?

tpex/4105 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4105 analysis?

The full report lives at /stocks/tpex/4105/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4105?

The latest report frames tpex/4105 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4105 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.